$ARQ

Arq, Inc. (ARQ): Results of Operations and Financial Condition

Arq, Inc. (ARQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991pressreleaseq22026_081.htm EX-99.1 Document Exhibit 99.1 Arq Reports Second Quarter 2026 Results Generated revenue of approximately $30 million, up 5% Reported Adjusted EBITDA (1) of approximately $5.8 million, up 59% on prior year period 9 th consecutive quarter of

Original reporting
Published Aug 10, 2026, 8:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ARQ
Bullish
medium confidence
Mentioned
$ARQ
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARQBullishMed
01

Why it matters

Traders can update valuation and positioning based on the quarter’s profitability improvement, gross margin expansion, and the reaffirmed full-year revenue and Adjusted EBITDA range.

02

Market read

Fresh quarterly financials plus explicit guidance reaffirmation typically drive near-term repricing for small-cap industrials, especially when profitability metrics improve materially.

03

What to watch

Large restricted cash balance and the reliance on non-GAAP Adjusted EBITDA could mask underlying cash flow volatility; severance and recruiting costs also rose year over year.

Relevance 7/10Novelty 7/10Timing: after-hours filing on Aug 10, 2026 (Q2 results and guidance reaffirmation)

Background

This SEC 8-K includes Arq’s Q2 2026 results (Item 2.02) and an attached earnings release (Exhibit 99.1).

Company-level read

Ticker impact

$ARQBullishMedium confidence
Context

Arq reported Q2 2026 revenue of $29.9M, Adjusted EBITDA of $5.8M, and reaffirmed 2026 guidance of $120-125M revenue and $17-20M Adjusted EBITDA.

Expected impact

Likely positive bias for ARQ shares on guidance confidence, with follow-through dependent on continued PAC margin and PFAS/PAC commercialization progress.

Evidence & confidence

The filing provides fresh quarterly datapoints (revenue, gross margin, net loss, Adjusted EBITDA) plus explicit reaffirmed full-year targets, which are actionable for traders repricing the earnings power outlook.

Market effects

Reinforces demand and margin durability for activated carbon/PAC used in water purification and PFAS mitigation, a niche environmental services/materials theme.

No clear regional spillover beyond US-listed small-cap industrial/environmental materials sentiment.

Limited global relevance; story is company-specific with PFAS-related commercialization optionality.

Counterpoint

Despite strong Adjusted EBITDA, the company still reported a net loss and carries execution risk around GAC expansion, PFAS for PAC scaling, and monetizing the Corbin Facility.

Key entities

  • Arq, Inc.

    Producer of activated carbon and related environmentally efficient carbon products; reported Q2 2026 results and reaffirmed 2026 guidance.

  • Bob Rasmus

    CEO quoted on PAC earnings power, turnaround completion, and PFAS-related PAC strategy progress.

  • Shimon Steinmetz

    Appointed CFO in May 2026, started July 2026.

Related articles

$HNRGMed

HALLADOR ENERGY CO (HNRG): Results of Operations and Financial Condition

HALLADOR ENERGY CO (HNRG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hnrg-20260810xex99d1.htm EX-99.1 EXHIBIT 99.1 ​ Hallador Reports Q2 2026 Results; Gas Project Budget Reduced Below $800 Million ​ - Turtle Creek COD Expedited to the Second Half of 2028 - ​ - Contracted Forward Sales Reach $2.4 Billion at the Segment Level - ​ - Managem

$NOTEMed

FiscalNote Holdings, Inc. (NOTE): Results of Operations and Financial Condition

FiscalNote Holdings, Inc. (NOTE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 note-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FiscalNote Reports Second Quarter 2026 Financial Results Total Revenue In Line with Guidance; Adjusted EBITDA Slightly Below Guidance; Establishes Q3 2026 Forecast and Revises FY26 Guidance Company To Host Conference Call Tod

$HLIOHigh

HELIOS TECHNOLOGIES, INC. (HLIO): Results of Operations and Financial Condition

HELIOS TECHNOLOGIES, INC. (HLIO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hlio-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE 35 m+ FOR IMMEDIATE RELEASE Helios Technologies Reports Second Quarter 2026 Results; Profitable Sales Growth Momentum Continues, Raising Full Year 2026 Outlook • Grew 2Q26 sales to $232 million, up 9% over prior

$BCSFMed

Bain Capital Specialty Finance, Inc. (BCSF): Results of Operations and Financial Condition

Bain Capital Specialty Finance, Inc. (BCSF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bcsf-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Bain Capital Specialty Finance, Inc. Bain Capital Specialty Finance, Inc. Announces June 30, 2026 Financial Results and Declares Third Quarter 2026 Dividend of $0.42 per Share BOSTON – August 10, 2026 – Bain Capital Specialty

$PRPLMed

Purple Innovation, Inc. (PRPL): Results of Operations and Financial Condition

Purple Innovation, Inc. (PRPL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030125701ex99-1.htm PRESS RELEASE DATED AUGUST 10, 2026, REGARDING FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026 Exhibit 99.1 Purple Innovation Reports Second Quarter 2026 Results Showroom Revenue Up 16.6% and Comparable Revenue Up 18% GAAP Net Loss of

$HIMSMedAI 8/10

Why is Hims & Hers Health stock sliding today?

Hims & Hers Health shares fell about 1.5% in after-hours after Q2 2026 results. Revenue rose to $753M (+38% YoY) but EPS was a loss of -$0.37 versus -$0.05 expected, tied to gross margin contracting 12 points from a shift from compounded to branded GLP-1. The company raised FY2026 revenue to $3.1B-$3.3B and Q3 guidance to $880M-$900M, but legal and regulatory overhangs and softer GLP-1 billing weighed.